Pharmaceutical company IBSA Derma has published its fourth sustainability report with the aim to reduce its environmental footprint.
According to the company, the fourth report presents a more in-depth environmental analysis, and results show how IBSA is pursuing the goal to reduce its footprint and operate to a more efficient use of resources.
The report highlights a -24.4% in the use of fossil fuels in the Swiss subsidiary compared to 2018, -3% in water consumption in the Italian subsidiary compared to 2020, -22% in the production of waste in the Chinese subsidiary compared to 2020 and -7% in electricity consumption in the French subsidiary compared to 2019.
The company explains that the new report witnesses the completion of the transition which began in 2021 with the renovation of Cosmos, the largest production plant of the IBSA Group, located in the CorPharma sustainable district in Switzerland. The production hub is designed according to sustainability criteria, ranging from the selection of sustainable materials to the use of clean energy, to satisfy the increase in production through the installation of photovoltaic panels, explains IBSA.
Director of HA-Derma, the exclusive distributor of IBSA in the UK and Ireland, Iveta Vinkler, said, “It’s a privilege to be representing a company like IBSA who is not only leading the way in the hyaluronic acid innovation, but despite the global success the company has been experiencing in recent years, are not blind to the effects this can have on the environment and continue taking actions towards a more sustainable business.”
A copy of the report
is available to read here.